Nikhil Munshi

UNVERIFIED PROFILE

Are you Nikhil Munshi?   Register this Author

Register author

Nikhil Munshi

Publications by authors named "Nikhil Munshi"

Are you Nikhil Munshi?   Register this Author

100Publications

-Reads

Tolerance, Kinetics, and Depth of Response for Subcutaneous Versus Intravenous Administration of Bortezomib Combination in Chinese Patients With Newly Diagnosed Multiple Myeloma.

Clin Lymphoma Myeloma Leuk 2018 Jun 15;18(6):422-430. Epub 2018 Mar 15.

State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academic Medical Science and Peking Union Medical College, Tianjin, China. Electronic address:

View Article
June 2018

Widespread intronic polyadenylation diversifies immune cell transcriptomes.

Nat Commun 2018 Apr 30;9(1):1716. Epub 2018 Apr 30.

Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

View Article
April 2018

Diagnosis of Castleman Disease.

Hematol Oncol Clin North Am 2018 02;32(1):53-64

Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, M230 Boston, MA 02215, USA; VA Boston Healthcare System, 1400 VFW Parkway, West Roxbury, MA, USA. Electronic address:

View Article
February 2018

Castleman Disease.

Hematol Oncol Clin North Am 2018 02;32(1):xiii-xiv

Dana Farber Cancer Institute, VA Boston Healthcare System, Harvard Medical School, 450 Brookline Avenue, M230, Boston, MA 02215, USA. Electronic address:

View Article
February 2018

High content analysis identifies unique morphological features of reprogrammed cardiomyocytes.

Sci Rep 2018 Jan 19;8(1):1258. Epub 2018 Jan 19.

Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, 22908, USA.

View Article
January 2018

Determining therapeutic susceptibility in multiple myeloma by single-cell mass accumulation.

Nat Commun 2017 Nov 20;8(1):1613. Epub 2017 Nov 20.

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 500 Main St., Cambridge, MA, 02139, USA.

View Article
November 2017

Ribonucleotide Reductase Catalytic Subunit M1 (RRM1) as a Novel Therapeutic Target in Multiple Myeloma.

Clin Cancer Res 2017 Sep 25;23(17):5225-5237. Epub 2017 Apr 25.

Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

View Article
September 2017

Prospective Evaluation of Magnetic Resonance Imaging and [F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM/DFCI 2009 Trial: Results of the IMAJEM Study.

J Clin Oncol 2017 Sep 7;35(25):2911-2918. Epub 2017 Jul 7.

Philippe Moreau, Florence Caillon, Caroline Bodet-Milin, Aurelie Gaultier, Jean-Michel Nguyen, Benoit Dupas, Eric Frampas, and Françoise Kraeber-Bodere, University Hospital, Nantes; Michel Attal, University Hospital, Toulouse; Denis Caillot, University Hospital, Dijon; Margaret Macro, University Hospital, Caen; Lionel Karlin, University Hospital, Lyon; Laurent Garderet, University Hospital Saint-Antoine, Paris; Thierry Facon, University Hospital, Lille; Lotfi Benboubker, University Hospital, Tours; Martine Escoffre-Barbe, University Hospital, Rennes; Anne-Marie Stoppa, Institut Paoli-Calmettes, Marseille; Kamel Laribi, University Hospital, Le Mans; Cyrille Hulin and Gerald Marit, University Hospital, Bordeaux; Aurore Perrot, University Hospital, Nancy; Jean-Richard Eveillard, University Hospital, Brest; Brigitte Pegourie, University Hospital, Grenoble; Veronique Dorvaux, University Hospital, Metz; Carine Chaleteix, University Hospital, Clermont-Ferrand; and Herve Avet-Loiseau, University Hospital, Toulouse, France; and Kenneth Anderson, Paul Richardson, and Nikhil C. Munshi, Dana-Farber Cancer Institute, Boston, MA.

View Article
September 2017

Targeting CD38 Suppresses Induction and Function of T Regulatory Cells to Mitigate Immunosuppression in Multiple Myeloma.

Clin Cancer Res 2017 Aug 1;23(15):4290-4300. Epub 2017 Mar 1.

LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

View Article
August 2017

Blockade of Deubiquitylating Enzyme USP1 Inhibits DNA Repair and Triggers Apoptosis in Multiple Myeloma Cells.

Clin Cancer Res 2017 Aug 7;23(15):4280-4289. Epub 2017 Mar 7.

LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article
August 2017

Phenotypically silent Cre recombination within the postnatal ventricular conduction system.

PLoS One 2017 30;12(3):e0174517. Epub 2017 Mar 30.

Department of Internal Medicine (Cardiology Division), UT Southwestern Medical Center, Dallas, TX, United States of America.

View Article
August 2017

Myeloma Minimal Residual Disease and Surrogacy-Reply.

JAMA Oncol 2017 Aug;3(8):1136-1137

Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, England.

View Article
August 2017

Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma.

N Engl J Med 2017 04;376(14):1311-1320

From the Institut Universitaire du Cancer de Toulouse-Oncopole (M.A., M.R., C.P., S.R., H.A.-L.) and Service d'Epidémiologie, Centre Hospitalier et Universitaire de Toulouse (V.L.-C.), Toulouse, Hôpital Haut-Lévêque, Bordeaux Pessac (C.H.), Centre Hospitalier et Universitaire la Miletrie, Poitiers (X.L.), Centre Hospitalier Le Bocage, Dijon (D.C.), Centre Hospitalier et Universitaire de Rennes, Rennes (M.E.), Hôpital St.-Louis (B.A., J.P.F.), Centre Hospitalier Universitaire, Hôpital St.-Antoine (L.G.), Institut Curie (C.M.), and Haute Autorité de Santé (J.-L.H.), Paris, Institut d'Hématologie de Basse Normandie, Centre Hospitalier et Universitaire de Caen, Caen (M.M.), Centre Hospitalier et Universitaire Henri Mondor, Creteil (K.B.), Hôpital Claude Huriez, Lille (T.F.), and Hôtel Dieu, Nantes (P.M.) - all in France; Institut Jules Bordet, Brussels (N. Meuleman); and Dana-Farber Cancer Institute, Boston (M.E.M., A.A.Z., E.A.W., N. Munshi, K.C.A., P.G.R.).

View Article
April 2017

Resident Macrophages: Near and Dear to Your Heart.

Authors:
Nikhil V Munshi

Cell 2017 04;169(3):376-377

Department of Internal Medicine, Division of Cardiology, UT Southwestern Medical Center, Dallas, TX 75390, USA; McDermott Center for Human Growth and Development, UT Southwestern Medical Center, Dallas, TX 75390, USA; Department of Molecular Biology, UT Southwestern Medical Center, Dallas, TX 75390, USA; Hamon Center for Regenerative Science and Medicine, UT Southwestern Medical Center, Dallas, TX 75390, USA. Electronic address:

View Article
April 2017

The Promise of Cardiac Regeneration by In Situ Lineage Conversion.

Circulation 2017 Mar;135(10):914-916

From Department of Medicine, Division of Cardiovascular Medicine, Vanderbilt University, Nashville, TN (Y.-J.N.); Department of Internal Medicine, Division of Cardiology, UT Southwestern Medical Center, Dallas, TX (N.V.M.); McDermott Center for Human Growth and Development, UT Southwestern Medical Center, Dallas, TX (N.V.M.); Department of Molecular Biology, UT Southwestern Medical Center, Dallas, TX (N.V.M.); and Hamon Center for Regenerative Science and Medicine, UT Southwestern Medical Center, Dallas, TX (N.V.M.).

View Article
March 2017

Genomics of Multiple Myeloma.

J Clin Oncol 2017 Mar 13;35(9):963-967. Epub 2017 Feb 13.

Sebastien Robiou du Pont, Charlotte Fontan, Michel Attal, Jill Corre, and Hervé Avet-Loiseau, L'Institut Universitaire du Cancer Oncopole, Toulouse; Alice Cleynen, Centre National de la Recherche Scientifique, and Montpellier University, Montpellier, France; and Nikhil Munshi, Dana-Farber Cancer Institute, Boston, MA.

View Article
March 2017

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts.

J Vis Exp 2017 03 22(121). Epub 2017 Mar 22.

Department of Internal Medicine- Cardiology, UT Southwestern Medical Center;

View Article
March 2017

Impact of RAD51C-mediated Homologous Recombination on Genomic Integrity in Barrett's Adenocarcinoma Cells.

J Gastroenterol Hepatol Res 2017 21;6(1):2286-2295. Epub 2017 Feb 21.

Department of Adult Oncology, Harvard (Dana Farber) Cancer Institute, Boston, MA, the United States. VA Health Care System, West Roxbury, MA, the United States.

View Article
February 2017

Next-Generation Sequencing Informing Therapeutic Decisions and Personalized Approaches.

Am Soc Clin Oncol Educ Book 2016 ;35:e442-8

From the Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; VA Boston Healthcare System, Boston, MA.

View Article
January 2017

A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci.

Authors:
Kristin A Rand Chi Song Eric Dean Daniel J Serie Karen Curtin Xin Sheng Donglei Hu Carol Ann Huff Leon Bernal-Mizrachi Michael H Tomasson Sikander Ailawadhi Seema Singhal Karen Pawlish Edward S Peters Cathryn H Bock Alex Stram David J Van Den Berg Christopher K Edlund David V Conti Todd Zimmerman Amie E Hwang Scott Huntsman John Graff Ajay Nooka Yinfei Kong Silvana L Pregja Sonja I Berndt William J Blot John Carpten Graham Casey Lisa Chu W Ryan Diver Victoria L Stevens Michael R Lieber Phyllis J Goodman Anselm J M Hennis Ann W Hsing Jayesh Mehta Rick A Kittles Suzanne Kolb Eric A Klein Cristina Leske Adam B Murphy Barbara Nemesure Christine Neslund-Dudas Sara S Strom Ravi Vij Benjamin A Rybicki Janet L Stanford Lisa B Signorello John S Witte Christine B Ambrosone Parveen Bhatti Esther M John Leslie Bernstein Wei Zheng Andrew F Olshan Jennifer J Hu Regina G Ziegler Sarah J Nyante Elisa V Bandera Brenda M Birmann Sue A Ingles Michael F Press Djordje Atanackovic Martha J Glenn Lisa A Cannon-Albright Brandt Jones Guido Tricot Thomas G Martin Shaji K Kumar Jeffrey L Wolf Sandra L Deming Halverson Nathaniel Rothman Angela R Brooks-Wilson S Vincent Rajkumar Laurence N Kolonel Stephen J Chanock Susan L Slager Richard K Severson Nalini Janakiraman Howard R Terebelo Elizabeth E Brown Anneclaire J De Roos Ann F Mohrbacher Graham A Colditz Graham G Giles John J Spinelli Brian C Chiu Nikhil C Munshi Kenneth C Anderson Joan Levy Jeffrey A Zonder Robert Z Orlowski Sagar Lonial Nicola J Camp Celine M Vachon Elad Ziv Daniel O Stram Dennis J Hazelett Christopher A Haiman Wendy Cozen

Cancer Epidemiol Biomarkers Prev 2016 12 1;25(12):1609-1618. Epub 2016 Sep 1.

Keck School of Medicine of USC and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California.

View Article
December 2016

Review of siltuximab in the treatment of multicentric Castleman's disease.

Ther Adv Hematol 2016 Dec 23;7(6):360-366. Epub 2016 Jun 23.

Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA.

View Article
December 2016

Deficiency of the immunostimulatory cytokine IL-21 promotes intestinal neoplasia via dysregulation of the Th1/Th17 axis.

Oncoimmunology 2017 7;6(1):e1261776. Epub 2016 Dec 7.

Harvard Medical School, Boston, MA, USA; Brigham and Women's Hospital, Boston, MA, USA; Surgery Services, VA Boston Healthcare System, West Roxbury, MA, USA.

View Article
December 2016

A novel 3D mesenchymal stem cell model of the multiple myeloma bone marrow niche: biologic and clinical applications.

Oncotarget 2016 Nov;7(47):77326-77341

Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Department of Medical Oncology, Boston, MA, USA.

View Article
November 2016

Gene Expression Profiles in Myeloma: Ready for the Real World?

Clin Cancer Res 2016 Nov;22(22):5434-5442

Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

View Article
November 2016

Deep Response in Multiple Myeloma: A Critical Review.

Biomed Res Int 2015 10;2015:832049. Epub 2015 Dec 10.

Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Department of hematology, Hospital 12 de Octubre, Unidad CRIS, CNIO, University of Madrid, Spain.

View Article
October 2016

Osteoclasts promote immune suppressive microenvironment in multiple myeloma: therapeutic implication.

Blood 2016 09 14;128(12):1590-603. Epub 2016 Jul 14.

LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and.

View Article
September 2016

DNA repair of myeloma plasma cells correlates with clinical outcome: the effect of the nonhomologous end-joining inhibitor SCR7.

Blood 2016 09 21;128(9):1214-25. Epub 2016 Jul 21.

Institute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, Athens, Greece.

View Article
September 2016

CRISPR (Clustered Regularly Interspaced Palindromic Repeat)/Cas9 System: A Revolutionary Disease-Modifying Technology.

Authors:
Nikhil V Munshi

Circulation 2016 Sep;134(11):777-9

From Department of Internal Medicine, Division of Cardiology, UT Southwestern Medical Center; McDermott Center for Human Growth and Development, UT Southwestern Medical Center; Department of Molecular Biology, UT Southwestern Medical Center; and Hamon Center for Regenerative Science and Medicine, UT Southwestern Medical Center; Dallas, TX.

View Article
September 2016

Impact of Genes Highly Correlated with MMSET Myeloma on the Survival of Non-MMSET Myeloma Patients.

Clin Cancer Res 2016 Aug 4;22(16):4039-44. Epub 2016 Feb 4.

Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article
August 2016

Transcriptome sequencing reveals a profile that corresponds to genomic variants in Waldenström macroglobulinemia.

Blood 2016 08 14;128(6):827-38. Epub 2016 Jun 14.

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA; Department of Medicine, Harvard Medical School, Boston, MA;

View Article
August 2016

Stromal CCR6 drives tumor growth in a murine transplantable colon cancer through recruitment of tumor-promoting macrophages.

Oncoimmunology 2016 Aug 24;5(8):e1189052. Epub 2016 May 24.

Harvard Medical School, Boston, MA, USA; Brigham and Women's Hospital, Boston, MA, USA; Surgery Service, VA Boston Healthcare System, West Roxbury, MA, USA.

View Article
August 2016

A clinically relevant in vivo zebrafish model of human multiple myeloma to study preclinical therapeutic efficacy.

Blood 2016 07 18;128(2):249-52. Epub 2016 May 18.

Medical Oncology, and LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA; VA Boston Healthcare System, Boston, MA.

View Article
July 2016

APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment.

Blood 2016 06 28;127(25):3225-36. Epub 2016 Apr 28.

The Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Medicine, Harvard Medical School, Boston, MA;

View Article
June 2016

Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple Myeloma.

Mol Cancer Ther 2016 06 18;15(6):1364-75. Epub 2016 May 18.

Department of Experimental and Clinical Medicine, Magna Graecia University and Translational Medical Oncology Unit, Salvatore Venuta University Campus, Catanzaro, Italy. Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania.

View Article
June 2016

Corrigendum to "Genomic heterogeneity in multiple myeloma" [Curr. Opin. Genet. Dev. 30 (2015) 56-65].

Curr Opin Genet Dev 2016 Apr 4;37:158. Epub 2016 Mar 4.

Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States; VA Boston Healthcare System, Boston, MA, United States. Electronic address:

View Article
April 2016

A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells.

Clin Cancer Res 2016 Mar 2;22(5):1222-33. Epub 2015 Nov 2.

Department of Experimental and Clinical Medicine, Magna Græcia University, Campus Salvatore Venuta, Catanzaro, Italy. Center for Biotechnology, Sbarro Institute for Cancer Research and Molecular Medicine, College of Science and Technology, Temple University, Philadelphia, Pennsylvania.

View Article
March 2016

Role of FDG-PET/CT in Extramedullary Multiple Myeloma: Correlation of FDG-PET/CT Findings With Clinical Outcome.

Clin Nucl Med 2016 Jan;41(1):e7-13

From the *Department of Imaging, Dana-Farber Cancer Institute, †Department of Radiology, Brigham and Women's Hospital, and ‡Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

View Article
January 2016

Solitary Extramedullary Multiple Myeloma Presenting with Small Bowel Obstruction.

J Emerg Med 2016 Jan 4;50(1):e25-7. Epub 2015 Oct 4.

Department of Hematologic Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

View Article
January 2016

Cancer Cell Dissemination and Homing to the Bone Marrow in a Zebrafish Model.

Cancer Res 2016 Jan 7;76(2):463-71. Epub 2016 Jan 7.

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

View Article
January 2016

CCR6, the sole receptor for the chemokine CCL20, promotes spontaneous intestinal tumorigenesis.

PLoS One 2014 27;9(5):e97566. Epub 2014 May 27.

Harvard Medical School, Boston, Massachusetts, United States of America; Surgery Service, VA Boston Healthcare System, West Roxbury, Massachusetts, United States of America; Brigham and Women's Hospital, Boston, Massachusetts, United States of America.

View Article
December 2015

Association of Agent Orange With Plasma Cell Disorder: Further Evidence.

Authors:
Nikhil C Munshi

JAMA Oncol 2015 Nov;1(8):1035-6

VA Boston Healthcare System, Boston, Massachusetts2Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

View Article
November 2015

The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cells.

Nat Med 2015 Jun 25;21(6):572-80. Epub 2015 May 25.

1] Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. [2] Department of Pathology, Brigham &Women's Hospital, Boston, Massachusetts, USA.

View Article
June 2015

Lenalidomide Polarizes Th1-specific Anti-tumor Immune Response and Expands XBP1 Antigen-Specific Central Memory CD3CD8 T cells against Various Solid Tumors.

J Leuk (Los Angel) 2015 Jun 21;3(2). Epub 2015 Apr 21.

Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA.

View Article
June 2015

Use of a claims database to characterize and estimate the incidence rate for Castleman disease.

Leuk Lymphoma 2015 May 29;56(5):1252-60. Epub 2014 Sep 29.

Dana-Farber Cancer Institute, Harvard Medical School , Boston, MA , USA.

View Article
May 2015

Pathogenesis beyond the cancer clone(s) in multiple myeloma.

Blood 2015 May 2;125(20):3049-58. Epub 2015 Apr 2.

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and Veterans Affairs Boston Healthcare System, West Roxbury, MA.

View Article
May 2015

Genetics of multiple myeloma: another heterogeneity level?

Blood 2015 Mar 27;125(12):1870-6. Epub 2015 Jan 27.

Unit for Genomics in Myeloma, L'Institut Universitaire du Cancer de Toulouse-Oncopole, Centre Hospitalier Universitaire, Toulouse, France; Centre de Recherche en Cancérologie de Toulouse Institut National de la Santé et de la Recherche Médicale U1037, Toulouse, France;

View Article
March 2015

MyoR modulates cardiac conduction by repressing Gata4.

Mol Cell Biol 2015 Feb 8;35(4):649-61. Epub 2014 Dec 8.

Department of Internal Medicine (Cardiology Division), UT Southwestern Medical Center, Dallas, Texas, USA Department of Molecular Biology, UT Southwestern Medical Center, Dallas, Texas, USA Hamon Center for Regenerative Science and Medicine, UT Southwestern Medical Center, Dallas, Texas, USA McDermott Center for Human Growth and Development, UT Southwestern Medical Center, Dallas, Texas, USA

View Article
February 2015

Genomic heterogeneity in multiple myeloma.

Curr Opin Genet Dev 2015 Feb 16;30:56-65. Epub 2015 May 16.

Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States; VA Boston Healthcare System, Boston, MA, United States. Electronic address:

View Article
February 2015

Early or delayed transplantation for multiple myeloma in the era of novel therapy: does one size fit all?

Hematology Am Soc Hematol Educ Program 2014 Dec 18;2014(1):255-61. Epub 2014 Nov 18.

Dana-Farber Cancer Institute, Boston, MA.

View Article
December 2014

Differential and limited expression of mutant alleles in multiple myeloma.

Blood 2014 Nov 18;124(20):3110-7. Epub 2014 Sep 18.

Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Department of Hematology/Oncology, Boston Veterans Administration Healthcare System, West Roxbury, MA;

View Article
November 2014

Induction of diverse cardiac cell types by reprogramming fibroblasts with cardiac transcription factors.

Development 2014 Nov 24;141(22):4267-78. Epub 2014 Oct 24.

Department of Molecular Biology, UT Southwestern Medical Center, Dallas, TX 75390, USA Department of Internal Medicine, Division of Cardiology, UT Southwestern Medical Center, Dallas, TX 75390, USA McDermott Center for Human Growth and Development, UT Southwestern Medical Center, Dallas, TX 75390, USA

View Article
November 2014

Immunotherapy strategies in multiple myeloma.

Hematol Oncol Clin North Am 2014 Oct;28(5):927-43

Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA.

View Article
October 2014

Translational medicine. Improving cardiac rhythm with a biological pacemaker.

Science 2014 Jul;345(6194):268-9

Department of Molecular Biology, UT Southwestern Medical Center, Dallas, TX 75390, USA. Center for Regenerative Science and Medicine, UT Southwestern Medical Center, Dallas, TX 75390, USA.

View Article
July 2014